Evodiamine, a novel plant alkaloid, relatively selectively inhibited growth and survival of human lung cancer cells.
Increased cancer cell apoptosis involving mitochondrial membrane depolarization.
Increased the cytochrome-c release from mitochondria into the cytosol as well as nucleus.
DR5 and caspase-8 extrinsic pathway was also activated in p53-independent manner.
Thus evodiamine could be a potential anticancer agent against lung cancer.